Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Prepaid Assets (2016 - 2021)

Historic Prepaid Assets for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $50.5 million.

  • Neurocrine Biosciences' Prepaid Assets rose 4553.31% to $50.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $50.5 million, marking a year-over-year increase of 4553.31%. This contributed to the annual value of $30.1 million for FY2020, which is 8132.53% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Prepaid Assets stood at $50.5 million for Q3 2021, which was up 4553.31% from $38.4 million recorded in Q2 2021.
  • In the past 5 years, Neurocrine Biosciences' Prepaid Assets ranged from a high of $50.5 million in Q3 2021 and a low of $3.9 million during Q1 2017
  • Its 5-year average for Prepaid Assets is $21.7 million, with a median of $21.5 million in 2019.
  • Per our database at Business Quant, Neurocrine Biosciences' Prepaid Assets tumbled by 1156.04% in 2017 and then surged by 19464.64% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Prepaid Assets (Quarter) stood at $6.8 million in 2017, then surged by 171.88% to $18.6 million in 2018, then fell by 10.72% to $16.6 million in 2019, then soared by 81.33% to $30.1 million in 2020, then surged by 67.77% to $50.5 million in 2021.
  • Its Prepaid Assets was $50.5 million in Q3 2021, compared to $38.4 million in Q2 2021 and $33.8 million in Q1 2021.